Zimmer Biomet Holdings Inc

US

ZBH

Health Care

120.78 ₽

Current price

Buy
120.78 ₽

Target price 00%

Ranks rating

76

  • Position in sub-industry

    154 / 663

  • Position in country

    3050 / 14179

  • Return on Assets, %

    4.8

    -11.9

  • Net income margin, %

    21.6

    -12.5

  • EBITDA margin, %

    35

    -2.5

  • Debt to Equity, %

    46.2

    15

  • Intangible assets and goodwill, %

    63.6

    3.9

  • Revenue CAGR 3Y, %

    6.4

    12.6

  • Total Equity change 1Y, %

    3.8

    0

  • Revenue Y, % chg

    6.5

    4.6

  • P/E

    25.4

    28.3

  • P/BV

    2

    1.7

  • P/S

    3.4

    3.7

  • EV/S

    4.1

    3.2

  • EV/EBITDA

    12.7

    -0.2

  • Average Analyst recommendation

    Hold

    Hold

  • Average upside forecasts, %

    9.2

    66.5

  • Forward P/E

    15.1

    19.2

  • Dividend Yield, %

    0.7

    1.8

  • Forward Dividend Yield, %

    0.8

    0.2

  • Expected dividend per share

    1

    0

  • Payout Ratio, %

    19.5

    17.3

  • Dividend Ex Date

    2024-03-27

Get an analytical review of this company

Competitors

Ranks

  • Dexcom Inc

    00%

  • Zimmer Biomet Holdings Inc

    00%

  • Boston Scientific Corp

    00%

  • Intuitive Surgical Inc

    00%

  • Stryker Corp

    00%

  • Edwards Lifesciences Corp

    00%

  • IDEXX Laboratories Inc

    00%

  • Abbott Laboratories

    00%

  • GE Healthcare Technologies Inc

    00%

  • Becton Dickinson and Co

    00%

Ready-made portfolio of the best Russian stocks

  • Created by artificial intelligence
  • Verified by analysts
  • Available even to beginners

Company information

  • Country

    United States of America

  • Sector

    Health Care

  • Industry group

    Health Care Equipment & Services

  • Industry

    Health Care Equipment & Supplies

  • Sub-sector

    Health Care

  • Capitalization (millions of $)

    25575.8

  • Ticker

    ZBH.N

  • ISIN

    US98956P1021

  • IPO date

    2001-07-25

  • Availability on Russian exchanges

    Yes

  • Reporting for

    2024-02-23

  • Date fact. publication of reports

    2023-12-31

Company Description

Zimmer Biomet Holdings, Inc. is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions help treat patients suffering from disorders of, or injuries to, bones, joints or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas and Global Businesses, consisting principally of the United States and other North, Central and South American markets; Europe, Middle East and Africa (EMEA), consisting principally of France, Germany, Italy, Spain and the United Kingdom, and Asia Pacific, consisting primarily of Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong and Malaysia.